A Phase 2 Study to Evaluate the Safety and Efficacy of Pacritinib in Relapsed or Refractory Waldenström Macroglobulinemia
Clinical trial NCT06986174 · RECRUITING
Trial details
- NCT number
- NCT06986174
- Sponsor
- Shayna Sarosiek, MD
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-21
- Primary completion
- 2028-10-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.